NGFR and amyotrophic lateral sclerosis: Indeed, p75NTR antagonists have modest efficacy at delaying symptoms in ALS models, and engineered neurotrophins that do not bind to p75NTR are neuroprotective whereas wild type neurotrophins are not [13,14].